Available Technologies

No technologies match these criteria.
Schedule UC TechAlerts to receive an email when technologies are published that match this search. Click on the Save Search link above

Find technologies available for licensing from UCSF.

Discovery of Gene Overexpression Combinations to Improve Therapeutic T Cell Constructs with Pooled CRISPR Knockin Screens

Scientists at UCSF have developed a method for highly parallel testing of gene knockins/overexpression in combination with a cancer-specific T cell receptor (TCR) or chimeric antigen receptor (CAR). The method enables researchers to evaluate what constructs can improve anti-tumor efficacy of conventional T-cell therapies. 

Distinct Metabolic States Guide Maturation of Inflammatory and Tolerogenic Dendritic Cells

Scientists at UCSF and the Parker Institute of Cancer Immunotherapy have developed methods for characterizing dendritic cells as well as methods for identifying a dendritic cell as either an inflammatory or a tolerogenic dendritic cell. Their results provide important insights into previously obscured metabolic heterogeneity impacting immune profiles of immunogenic and tolerogenic dendritic cells (DC).

Human Antibody Targeting Cd146 And Uses Thereof

Brief description not available